Investigators conduct a retrospective study utilizing electronic health records from a large integrated healthcare system to explore the relationship between cumulative exposure to first-generation H1-antihistamines and the subsequent diagnosis of mild cognitive impairment (MCI) in older adults. The researchers identify a group of patients recently diagnosed with MCI and match them to a group of healthy controls with normal cognition, based on age, sex, and socioeconomic status. A review of pharmacy dispensing records over the preceding years is performed to determine the history of regular, high-dose H1-antihistamine use.
The investigators compile the following data:
| Patient Group | History of Regular H1-Antihistamine Use | No History of Regular H1-Antihistamine Use | Total |
|---|---|---|---|
| MCI (Cases) | |||
| Normal Cognition (Controls) |
Based on these findings, which of the following is the best estimate of the odds ratio for developing mild cognitive impairment associated with regular use of first-generation H1-antihistamines?
- A0.33
- B0.75
- C1.50
- D1.80
- 3.00Answer
Answer
Using a standard 2x2 contingency table, the formula is OR = (a / c) / (b / d), which algebraically simplifies to the cross-product ratio (a × d) / (b × c).
- = exposed cases =
- = unexposed cases =
- = exposed controls =
- = unexposed controls =
Plugging these values into the formula:
This means that the odds of having a history of regular H1-antihistamine use were 3 times higher in patients who developed mild cognitive impairment compared to the healthy controls.